Related Experiment Video
Updated: Jul 10, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
Published on: February 9, 2011
Glucocorticoids and invasive fungal infections
Michail S Lionakis1, Dimitrios P Kontoyiannis
1Department of Infectious Diseases, Infection Control and Employee Health, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Abstract:
Since the 1990s, opportunistic fungal infections have emerged as a substantial cause of morbidity and mortality in profoundly immunocompromised patients. Hypercortisolaemic patients, both those with endogenous Cushing's syndrome and, much more frequently, those receiving exogenous glucocorticoid therapy, are especially at risk of such infections. This vulnerability is attributed to the complex dysregulation of immunity caused by glucocorticoids. We critically review the spectrum and presentation of invasive fungal infections that arise in the setting of hypercortisolism, and the ways in which glucocorticoids contribute to their pathogenesis. A better knowledge of the interplay between glucocorticoid-induced immunosuppression and invasive fungal infections should assist in earlier recognition and treatment of such infections. Efforts to decrease the intensity of glucocorticoid therapy should help to improve outcomes of opportunistic fungal infections.
Insights
Patients with hypercortisolism, due to Cushing's syndrome or glucocorticoid therapy, face increased risk of invasive fungal infections. Understanding this link aids early detection and treatment, suggesting reduced glucocorticoid therapy may improve outcomes.
Area of Science:
- Immunology
- Infectious Diseases
- Endocrinology
Background:
- Opportunistic fungal infections are a major cause of death in immunocompromised individuals.
- Hypercortisolism, from Cushing's syndrome or glucocorticoid use, significantly elevates infection risk.
- Glucocorticoids disrupt immune regulation, increasing vulnerability to fungal pathogens.
Purpose of the Study:
- To review the spectrum and presentation of invasive fungal infections in hypercortisolemic patients.
- To elucidate the role of glucocorticoids in the pathogenesis of these infections.
- To improve recognition and treatment strategies for these opportunistic infections.
Main Methods:
- Literature review of invasive fungal infections in hypercortisolemic states.
- Analysis of the mechanisms by which glucocorticoids induce immunosuppression.
- Synthesis of current knowledge on clinical presentation and pathogenesis.
Main Results:
- Invasive fungal infections present uniquely in hypercortisolemic patients.
- Glucocorticoids impair multiple arms of the immune system, facilitating fungal invasion.
- Specific fungal species and their clinical manifestations are detailed.
Conclusions:
- Enhanced understanding of glucocorticoid-induced immunosuppression is crucial for managing invasive fungal infections.
- Earlier diagnosis and targeted treatment are essential for improving patient outcomes.
- Modulating glucocorticoid therapy intensity may mitigate the risk and severity of these infections.
Related Concept Videos
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Drug toxicity: Drug–Drug Interaction
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are typically...
The Skin Microbiota
Staphylococcal Skin Infections
Candidiasis

